Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of drospirenone + ethinyl estradiol tablet vs Yasmin in healthy Thai women under fasting
TCTR20190604002Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of drospirenone and ethinyl estradiol + drospirenone in contraception (2 arms), sponsored by Bio-innova. Primary endpoints: Bioequivalence pharmacokinetic parameters for drospirenone and Bioequivalence pharmacokinetic parameters for ethinyl estradiol. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
drospirenoneethinyl estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20190604002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190604002.